Webster Cavenee
University of California, San Diego
H-index: 133
North America-United States
Top articles of Webster Cavenee
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Methods of treating neoplastic astrocytoma | 2021/2/4 | ||
Methods and biomarkers in cancer | 2024/3/21 | ||
DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma | Acta Neuropathologica Communications | Mio Harachi Kenta Masui Erika Shimizu Kumiko Murakami Hiromi Onizuka | 2024/3/13 |
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts | eLife | Richard C Lauer Marc Barry Tracey L Smith Andrew Maltez Thomas Jin Wu | 2023/1/16 |
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis | Proceedings of the National Academy of Sciences | Santanu Maji Anjan K Pradhan Amit Kumar Praveen Bhoopathi Padmanabhan Mannangatti | 2023/11/7 |
UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA | M Weller B Alexander D Berry N Blondin M Buxton | 2023 | |
CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB | Neuro-Oncology | Patrick Wen Brian Alexander Donald Berry Meredith Buxton Webster Cavenee | 2023/11/1 |
P11. 29. B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA | Neuro-oncology (Charlottesville, Va.) | M Weller B Alexander D Berry N Blondin M Buxton | 2023/9/8 |
Abstract CT062: GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma | Cancer Research | Ingo K Mellinghoff Brian Alexander Donald Berry Nicholas Blondin Meredith Buxton | 2023/4/14 |
Compositions and methods for inhibiting expression of mutant egfr gene | 2021/11/11 | ||
The metabolomic landscape plays a critical role in glioma oncogenesis | Kenta Masui Webster K Cavenee Paul S Mischel Noriyuki Shibata | 2022/5 | |
Somatic 9p24.1 alterations in HPV– head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activity | Proceedings of the National Academy of Sciences | Xin Zhao Ezra EW Cohen William N William Jr Joy J Bianchi Jim P Abraham | 2022/11/22 |
CTNI-38. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA | Neuro-Oncology | Meredith Buxton Brian Alexander Donald Berry Webster Cavenee Howard Colman | 2022/11/1 |
P11. 65. B GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple treatment regimens in newly diagnosed and recurrent glioblastoma | Neuro-Oncology | M Weller B Ellingson B Alexander P Wen E Sulman | 2022/9/1 |
Immune evasion in HPV− head and neck precancer–cancer transition is driven by an aneuploid switch involving chromosome 9p loss | Proceedings of the National Academy of Sciences | William N William Jr Xin Zhao Joy J Bianchi Heather Y Lin Pan Cheng | 2021/5/11 |
Insights into the mechanisms of action of MDA-7/IL-24: A ubiquitous cancer-suppressing protein | Jinkal Modi Abhishek Roy Anjan K Pradhan Amit Kumar Sarmistha Talukdar | 2021/12/22 | |
Protein acetylation at the interface of genetics, epigenetics and environment in cancer | Mio Harachi Kenta Masui Webster K Cavenee Paul S Mischel Noriyuki Shibata | 2021/4/1 | |
A mathematical model to estimate chemotherapy concentration at the tumor-site and predict therapy response in colorectal cancer patients with liver metastases | Cancers | Daniel A Anaya Prashant Dogra Zhihui Wang Mintallah Haider Jasmina Ehab | 2021/1/25 |
Anticorpo anti-receptor do fator de crescimento epidérmico (egfr) isolado e imunoconjugado compreendendo um agente citotóxico eo dito anticorpo | 2021/6/1 | ||
Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β | Proceedings of the National Academy of Sciences | Anjan K Pradhan Santanu Maji Praveen Bhoopathi Sarmistha Talukdar Padmanabhan Mannangatti | 2021/5/25 |
